Research ArticleCancer

Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index

See allHide authors and affiliations

Science Translational Medicine  16 Oct 2013:
Vol. 5, Issue 207, pp. 207ra144
DOI: 10.1126/scitranslmed.3006682

Log in to view full text


Navigate This Article